Kishi H - Search Results

1

Inhibition of IL-33 signaling ameliorate hepatic fibrosis with decreasing MCP-1 in a mouse model of diabetes and non-alcoholic steatohepatitis; comparison for luseogliflozin, an SGLT2 inhibitor.

Wakamatsu S, Jojima T, Hashiguchi M, Kishi H, Niitani T, Sakurai S, Iijima T, Kogai T, Tomaru T, Usui I, Aso Y. Wakamatsu S, et al. Among authors: kishi h. J Diabetes Complications. 2024 Jan;38(1):108650. doi: 10.1016/j.jdiacomp.2023.108650. Epub 2023 Nov 23. J Diabetes Complications. 2024. PMID: 38035640

2

Impact of dapagliflozin, an SGLT2 inhibitor, on serum levels of soluble dipeptidyl peptidase-4 in patients with type 2 diabetes and non-alcoholic fatty liver disease.

Aso Y, Kato K, Sakurai S, Kishi H, Shimizu M, Jojima T, Iijima T, Maejima Y, Shimomura K, Usui I. Aso Y, et al. Among authors: kishi h. Int J Clin Pract. 2019 May;73(5):e13335. doi: 10.1111/ijcp.13335. Epub 2019 Apr 1. Int J Clin Pract. 2019. PMID: 30810254 Clinical Trial.

3

Increased Number of Mucosal-Associated Invariant T Cells Is Associated with the Inhibition of Nonalcoholic Fatty Liver Disease in High Fat Diet-Fed Mice.

Kishi H, Usui I, Jojima T, Fujisaka S, Wakamatsu S, Mizunuma-Inoue Y, Niitani T, Sakurai S, Iijima T, Tomaru T, Tobe K, Aso Y. Kishi H, et al. Int J Mol Sci. 2022 Dec 4;23(23):15309. doi: 10.3390/ijms232315309. Int J Mol Sci. 2022. PMID: 36499635 Free PMC article.

4

A case of hypoparathyroidism, deafness, and renal dysplasia (HDR) syndrome with a novel frameshift variant in GATA3, p.W10Cfs40, lacks kidney malformation.

Kishi H, Jojima T, Kogai T, Iijima T, Ohira E, Tanuma D, Konno S, Kato K, Kezuka A, Akimoto K, Sakumoto J, Hishinuma A, Tomaru T, Makita N, Usui I, Aso Y. Kishi H, et al. Clin Case Rep. 2020 Aug 14;8(12):2619-2624. doi: 10.1002/ccr3.3186. eCollection 2020 Dec. Clin Case Rep. 2020. PMID: 33363791 Free PMC article.

5

Lack of impact of ipragliflozin on endothelial function in patients with type 2 diabetes: sub-analysis of the PROTECT study.

Kishimoto S, Higashi Y, Imai T, Eguchi K, Fukumoto K, Tomiyama H, Maemura K, Tanaka A, Node K; PROTECT investigators. Kishimoto S, et al. Cardiovasc Diabetol. 2023 May 20;22(1):119. doi: 10.1186/s12933-023-01856-x. Cardiovasc Diabetol. 2023. PMID: 37210524 Free PMC article. Clinical Trial.

6

Effect of ipragliflozin on carotid intima-media thickness in patients with type 2 diabetes: a multicenter, randomized, controlled trial.

Tanaka A, Sata M, Okada Y, Teragawa H, Eguchi K, Shimabukuro M, Taguchi I, Matsunaga K, Kanzaki Y, Yoshida H, Ishizu T, Ueda S, Kitakaze M, Murohara T, Node K; PROTECT study investigators. Tanaka A, et al. Eur Heart J Cardiovasc Pharmacother. 2023 Feb 2;9(2):165-172. doi: 10.1093/ehjcvp/pvac059. Eur Heart J Cardiovasc Pharmacother. 2023. PMID: 36308299 Free PMC article. Clinical Trial.

7

Long-term effects of ipragliflozin on blood pressure in patients with type 2 diabetes: insights from the randomized PROTECT trial.

Saito Y, Tanaka A, Imai T, Nakamura I, Kanda J, Matsuhisa M, Uehara H, Kario K, Kobayashi Y, Node K; PROTECT investigators. Saito Y, et al. Hypertens Res. 2024 Jan;47(1):168-176. doi: 10.1038/s41440-023-01494-6. Epub 2023 Nov 14. Hypertens Res. 2024. PMID: 37964067 Clinical Trial.

8

Theobromine improves hyperactivity, inattention, and working memory via modulation of dopaminergic neural function in the frontal cortex of spontaneously hypertensive rats.

Matsuzaki K, Sugimoto N, Hossain S, Islam R, Sumiyoshi E, Hashimoto M, Kishi H, Shido O. Matsuzaki K, et al. Among authors: kishi h. Food Funct. 2024 May 7. doi: 10.1039/d4fo00683f. Online ahead of print. Food Funct. 2024. PMID: 38713055

9

Threonine phosphorylation of STAT1 restricts interferon signaling and promotes innate inflammatory responses.

Metwally H, Elbrashy MM, Ozawa T, Okuyama K, White JT, Tulyeu J, Søndergaard JN, Wing JB, Muratsu A, Matsumoto H, Ikawa M, Kishi H, Taniuchi I, Kishimoto T. Metwally H, et al. Among authors: kishi h. Proc Natl Acad Sci U S A. 2024 Apr 23;121(17):e2402226121. doi: 10.1073/pnas.2402226121. Epub 2024 Apr 15. Proc Natl Acad Sci U S A. 2024. PMID: 38621137

10

Effect of Paxillin Expression and Phosphorylation on Colorectal Cancer Prognosis and Metastasis.

Zheng H, Tsunedomi R, Xu M, Zhang Y, Kishi H, Kobayashi S, Tomochika S, Nakajima M, Matsui H, Tokumitsu Y, Shindo Y, Iida M, Ioka T, Nagano H. Zheng H, et al. Among authors: kishi h. Anticancer Res. 2024 Feb;44(2):511-520. doi: 10.21873/anticanres.16839. Anticancer Res. 2024. PMID: 38307570

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

591 results

Search Page